LIVZON PHARMAC. GRP H YC1 Cash Flow Reinvestment Rate
LIVZON PHARMAC. GRP H YC1 cash flow reinvestment rate. LIVZON PHARMAC. GRP H YC1 (LP6) has a Cash Flow Reinvestment Rate of 0.60x as of December 2025, reinvesting €1.90 Billion (capex €574.14 Million plus investments €-1.33 Billion) from operating cash flow of €3.15 Billion. Explore LP6 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of LIVZON PHARMAC. GRP H YC1 (2021–2025)
Cash flow reinvestment rate of LIVZON PHARMAC. GRP H YC1 from 2021 to 2025. Historical reinvestment intensity for LIVZON PHARMAC. GRP H YC1 across 5 annual periods. Explore LIVZON PHARMAC. GRP H YC1 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
LIVZON PHARMAC. GRP H YC1 Cash Flow Reinvestment Rate by Year (2021–2025)
LIVZON PHARMAC. GRP H YC1 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for LIVZON PHARMAC. GRP H YC1. For the full cash flow conversion analysis, see how efficiently does LIVZON PHARMAC. GRP H YC1 generate cash.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | €1.90 Billion | €3.15 Billion | €574.14 Million | ▲ +174.0% |
| 2024 | 0.22x | €656.96 Million | €2.98 Billion | €570.16 Million | ▼ -25.7% |
| 2023 | 0.30x | €964.13 Million | €3.25 Billion | €820.45 Million | ▼ -31.9% |
| 2022 | 0.44x | €1.21 Billion | €2.77 Billion | €940.15 Million | ▼ -56.0% |
| 2021 | 0.99x | €1.89 Billion | €1.90 Billion | €1.31 Billion | — |